Evidence supporting the use of: Ginsenosides (unspecified)
For the health condition: Parkinson's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Ginsenosides, the primary active compounds in ginseng (Panax species), have been investigated for their neuroprotective effects, including potential applications in Parkinson's Disease (PD). Preclinical studies (in vitro and in vivo animal models) suggest that ginsenosides may exert beneficial effects in PD through anti-inflammatory, antioxidant, and anti-apoptotic mechanisms. Specifically, ginsenosides such as Rg1, Rb1, and Rd have demonstrated the ability to protect dopaminergic neurons against toxins like MPTP and 6-OHDA, which are commonly used to model PD in animals. These effects appear to involve modulation of neuroinflammatory pathways, reduction of oxidative stress, and inhibition of neuronal cell death.

However, human clinical evidence remains limited. Most published research consists of animal or cellular studies, with only a few small-scale pilot trials in humans, often lacking rigorous controls or sufficient sample sizes. As such, while there is a scientific rationale and some promising preclinical data supporting the use of ginsenosides in PD, the overall evidence base is weak, and high-quality clinical trials are needed to confirm efficacy and safety in humans. Therefore, the use of ginsenosides for Parkinson’s Disease is supported by scientific investigation, but the current level of evidence is low (rated 2 out of 5).

More about Ginsenosides (unspecified)
More about Parkinson's Disease

Products containing Ginsenosides (unspecified)

We currently have no products on Vitabase that contain this ingredient.